Article
Oral Belzutifan Treatment in von Hippel-Lindau-Associated Retinal Haemangioblastoma: A Promising Approach
2026-01-30
Abstract excerpt
<title>Abstract</title> <p>Objectives To assess the efficacy and safety of oral belzutifan in a real-world cohort of pretreated patients with von Hippel-Lindau (vHL)-associated retinal haemangioblastomas (RHs). Methods This retrospective observational study included genetically confirmed vHL patients with RHs, in whom at least one eye had been previously refractory to conventional ocular therapy. Patients recei...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7a38e51-0595-5e50-a91b-11118f1ce7f6
- DOI
- 10.21203/rs.3.rs-8503671/v1
